{$GTHX} Glancy Prongay & Murray LLP ("GPM") announces its investigation of G1 Therapeutics, Inc. (Nasdaq: GTHX) concerning the Company and its directors’ and officers’ possible violations of state laws.
Source: https://www.businesswire.com/news/home/20210126006040/en/